Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIMESULIDE vs NIRSEVIMAB-ALIP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIMESULIDE vs NIRSEVIMAB-ALIP: Safety Overview

Metric NIMESULIDE NIRSEVIMAB-ALIP
Total FAERS Reports 996 783
Deaths Reported 244 32
Death Rate 24.5% 4.1%
Hospitalizations 408 281
Average Patient Age 49.7 yrs 3.3 yrs
% Female Patients 66.5% 46.3%
Marketing Status N/A Prescription